L E Deelman Selected Research

Sul-121

11/2017

The Novel Compound Sul-121 Preserves Endothelial Function and Inhibits Progression of Kidney Damage in Type 2 Diabetes Mellitus in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L E Deelman Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 06/2008
1	Hyperhomocysteinemia 01/2022
1	Atherosclerosis 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Albuminuria 11/2017
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2017
1	Sclerosis 11/2017
1	Proteinuria 11/2016
1	Body Weight (Weight, Body) 11/2016
1	Ischemia 06/2008
1	Reperfusion Injury 06/2008
1	Acute Kidney Injury (Acute Renal Failure) 06/2008

Drug/Important Bio-Agent (IBA)

2	CreatinineIBA 11/2017 - 11/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	CholesterolIBA 01/2022
1	CystathionineIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Sul-121IBA 11/2017
1	Fibronectins (Fibronectin)IBA 11/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017
1	Interleukin-13IBA 06/2008
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 06/2008

Therapy/Procedure

1	Therapeutics 11/2017
1	Kidney Transplantation 06/2008